Marc Hömberg

7PUBLICATIONS
48CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 18, 2026
ADA2 genotype and enzyme activity may predict vasculitic or hematologic DADA2 phenotype.

|Dec 17, 2025
Dual checkpoint inhibitor therapy versus dual targeted therapy of untreated metastatic BRAF-mutant melanoma: a systematic review of randomised controlled trials.

Frank Peinemann, Sarah Baradaran, Kevin Bernhard Arnolds

|Dec 03, 2024
ELMO2-related intraosseous vascular malformation: new cases with novel pathogenic variants, clinical follow-up and therapeutic approaches.

Mert Karakaya, Iman Ragab, Vera Riehmer

|Oct 12, 2024
Metronomic chemotherapy for paediatric extracranial solid tumours: a systematic review and meta-analysis of randomised clinical trials.

Frank Peinemann, Marc Hoemberg

|Jun 01, 2024
Study protocol OKRA: orientation compass for the preparing, delivering and following up on breaking bad news conversations in paediatric oncology.

Theresia Krieger, Kerstin Dittmer, David Reinert

|Sep 27, 2021
Hypercalcemia is a frequent side effect of 13-cis-retinoic acid treatment in patients with high-risk neuroblastoma.

Marc Hoemberg, Ruth Schwenzfeur, Frank Berthold

Pageof 2

Frequent Collaborators

2 joint publications

Frank Peinemann

2 joint publications

Mert Karakaya

2 joint publications

Iman Ragab

2 joint publications

Vera Riehmer